ATE274067T1 - Verwendung von socs-2 oder cis zum 'screenen' von substanzen, die einen wachstumshormoneffekt verstärken - Google Patents

Verwendung von socs-2 oder cis zum 'screenen' von substanzen, die einen wachstumshormoneffekt verstärken

Info

Publication number
ATE274067T1
ATE274067T1 AT99956433T AT99956433T ATE274067T1 AT E274067 T1 ATE274067 T1 AT E274067T1 AT 99956433 T AT99956433 T AT 99956433T AT 99956433 T AT99956433 T AT 99956433T AT E274067 T1 ATE274067 T1 AT E274067T1
Authority
AT
Austria
Prior art keywords
cis
socs
screen
growth hormone
enhance
Prior art date
Application number
AT99956433T
Other languages
English (en)
Inventor
Gunnar Norstedt
Egnell Petra Tollet
Amilcar Flores Morales
Original Assignee
Sahltech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sahltech Ab filed Critical Sahltech Ab
Application granted granted Critical
Publication of ATE274067T1 publication Critical patent/ATE274067T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/61—Growth hormones [GH] (Somatotropin)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99956433T 1998-10-06 1999-10-06 Verwendung von socs-2 oder cis zum 'screenen' von substanzen, die einen wachstumshormoneffekt verstärken ATE274067T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803398A SE9803398D0 (sv) 1998-10-06 1998-10-06 "New use"
PCT/SE1999/001788 WO2000020624A1 (en) 1998-10-06 1999-10-06 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect

Publications (1)

Publication Number Publication Date
ATE274067T1 true ATE274067T1 (de) 2004-09-15

Family

ID=20412847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99956433T ATE274067T1 (de) 1998-10-06 1999-10-06 Verwendung von socs-2 oder cis zum 'screenen' von substanzen, die einen wachstumshormoneffekt verstärken

Country Status (8)

Country Link
EP (1) EP1121457B1 (de)
JP (1) JP2002526120A (de)
AT (1) ATE274067T1 (de)
AU (1) AU771281B2 (de)
CA (1) CA2343651A1 (de)
DE (1) DE69919558D1 (de)
SE (1) SE9803398D0 (de)
WO (1) WO2000020624A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2390555A1 (en) * 1999-11-16 2001-05-25 The Walter And Eliza Hall Institute Of Medical Research An animal model for studying hormone signalling and method of modulating the signalling
AU784277B2 (en) * 1999-11-16 2006-03-02 Walter And Eliza Hall Institute Of Medical Research, The An animal model for studying hormone signalling and method of modulating the signalling
AU2002950745A0 (en) * 2002-08-13 2002-09-12 The Walter And Eliza Hall Institute Of Medical Research A method and agents useful for same
EP3827838B1 (de) 2015-12-16 2023-06-07 The Walter and Eliza Hall Institute of Medical Research Hemmung von cytokininduziertem sh2-protein in nk-zellen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2331753A (en) * 1996-11-01 1999-06-02 Inst Medical W & E Hall Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines

Also Published As

Publication number Publication date
SE9803398D0 (sv) 1998-10-06
EP1121457A1 (de) 2001-08-08
AU1304600A (en) 2000-04-26
CA2343651A1 (en) 2000-04-13
JP2002526120A (ja) 2002-08-20
DE69919558D1 (de) 2004-09-23
EP1121457B1 (de) 2004-08-18
AU771281B2 (en) 2004-03-18
WO2000020624A1 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
ATE250426T1 (de) Verwendung von verbindungen die an ein zytoplasmatischen dipeptidase binden zur potenzierung des immunantworts
BR9508981A (pt) Mutantes de subtilisina isentos de cálcio
MX9800760A (es) Metodos para el tratamiento del asma alergica.
DE68914664D1 (de) Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden.
ES2148967T3 (es) Sustancias y metodos destinados al diagnostico y al tratamiento de la pre-eclampsia.
DE69117949D1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
DE69702705T2 (de) Kondensierte pyrrolo(2,3-c) carbazole-6-one die die aktivität von gamma interferon potenzieren
DE68903576T2 (de) Signalpeptide, die in hefe wirksam sind und ihre verwendung zur sekretorischen expression von heterologen proteinen.
AR069892A1 (es) Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion.
DE69523586D1 (de) Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen
DK0948604T3 (da) Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
ATE239274T1 (de) Proteom-analyse zum charakterisieren von auf- und abgeregelten proteinen in biologischen proben
DE69924009D1 (de) Methode zur verstärkung der biologischen aktivität von liganden
ATE274067T1 (de) Verwendung von socs-2 oder cis zum 'screenen' von substanzen, die einen wachstumshormoneffekt verstärken
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
NO994750D0 (no) Anti-Fas-antistoffer
NO981454D0 (no) Anti-FAS-antistoffer
DE602004026759D1 (de) Neue rekombinante tierzellen mit hoher proteinproduktion, verfahren zur konstruktion davon sowie verfahren zur massenproduktion von protein unter verwendung davon
CY1108849T1 (el) Πολλαπλασιαμος του ιου κορωνα των βοοειδων σε κυτταρα ωοθηκων κινεζικων κρικητων
DE69734890D1 (de) Rdgb-proteine
DE59611293D1 (de) Protein mit dnase-aktivität
DK0706567T3 (da) Peptidfamilie betegnet xenoxiner
DE69729780D1 (de) Protein mit Ethylendiamine-N,N'-Dibarnsteinsäure: Ethylendiamin Lyase Aktivität und dafür kodierendes Gen
DK0410147T3 (da) Modificerede VP1/P2A-regioner fra rhinovirale systemer
ATE209910T1 (de) Verwendung von 6,7-substituierter 2- aminotetraline zur behandlung von zytokin- vermittleten entzündungszuständen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties